imatinib mesylate has been researched along with Left Ventricular Hypertrophy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SR; Yhim, HY | 1 |
| Barst, RJ; Campbell, P; Peacock, A; Quinn, D; Rocha, GQ; Shah, AM; Solomon, SD | 1 |
| Chang, K; Choo, EH; Ihm, SH; Jang, SW; Kim, HY; Kim, OR; Park, CS; Seung, KB | 1 |
| Dengler, TJ; Hardt, SE; Katus, HA; Lossnitzer, D; Perz, JB; Volz, HC; Weiss, C; Zankl, AR | 1 |
1 trial(s) available for imatinib mesylate and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension.
Topics: Analysis of Variance; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Echocardiography, Doppler; Exercise Tolerance; Female; Humans; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Imatinib Mesylate; Male; Middle Aged; Observer Variation; Stroke Volume; Tricuspid Valve Insufficiency; Vascular Resistance; Ventricular Dysfunction, Right | 2015 |
3 other study(ies) available for imatinib mesylate and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Rapid left ventricular thickening and thrombus caused by FIP1L1/PDGFRA-negative hypereosinophilic syndrome.
Topics: Benzamides; Biopsy; Cerebral Infarction; Disease Progression; Echocardiography; Fibrosis; Genetic Predisposition to Disease; Hemodynamics; Humans; Hypereosinophilic Syndrome; Hypertrophy, Left Ventricular; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Middle Aged; Phenotype; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Thrombosis; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Topics: Animals; Benzamides; Blotting, Western; Collagen Type I; Collagen Type III; Fibroblasts; Fibrosis; Gene Expression; Hypertension; Hypertrophy, Left Ventricular; Imatinib Mesylate; Male; Myocardium; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta1; Ventricular Remodeling | 2014 |
Complete reversal of left ventricular mass in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia after therapy with imatinib.
Topics: Adult; Benzamides; Chronic Disease; Humans; Hypereosinophilic Syndrome; Hypertrophy, Left Ventricular; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Treatment Outcome | 2011 |